MGI Tech, Dasa partner to enhance genetic sequencing-based health diagnosis in Brazil

image credit- shutterstock

China’s MGI Tech announced that it has formed a strategic alliance with Dasa, the largest medical diagnostics company in Latin America, to expand Brazilian patients' access to next-generation genomics and promote significant advancements in Brazil's healthcare sector. The strategic alliance between MGI and Dasa aims to introduce state-of-the-art genomic sequencing technologies in the Brazilian healthcare market. Enabling Brazilian's access to genomic testing, more Brazilians can benefit from the latest advancements in precision medicine.

MGI operates in 100 countries and has been active in Latin America since 2019. In April of this year, MGI inaugurated the Customer Experience Center (CEC) in Brazil to strengthen genomic sequencing infrastructure and scientific development in the country. The company's technology also supports Brazil's largest genomic sequencing project, Genomas Brasil.

In addition to the established alliance, Dasa has implemented MGI's sequencers and automation products in its network of laboratories. The installation of high-throughput DNBSEQ-T7, Automated Sample Preparation System MGISP-100, Automated Sample Preparation System MGISP-960 and ZTRON Appliance equipment will optimize the time of professionals in processing procedures, reducing overall costs and significantly increases the efficiency of the laboratories.